Literature DB >> 27918691

Podoplanin Expression in Canine Melanoma.

Satoshi Ogasawara1, Ryusuke Honma1, Mika K Kaneko1, Yuki Fujii1, Yumiko Kagawa2, Satoru Konnai3, Yukinari Kato1.   

Abstract

A type I transmembrane protein, podoplanin (PDPN), is expressed in several normal cells such as lymphatic endothelial cells or pulmonary type I alveolar cells. We recently demonstrated that anticanine PDPN monoclonal antibody (mAb), PMab-38, recognizes canine PDPN of squamous cell carcinomas, but does not react with lymphatic endothelial cells. Herein, we investigated whether PMab-38 reacts with canine melanoma. PMab-38 reacted with 90% of melanoma cells (9/10 cases) using immunohistochemistry. Of interest, PMab-38 stained the lymphatic endothelial cells and cancer-associated fibroblasts in melanoma tissues, although it did not stain any lymphatic endothelial cells in normal tissues. PMab-38 could be useful for uncovering the function of PDPN in canine melanomas.

Entities:  

Keywords:  canine podoplanin; immunohistochemistry; melanoma; monoclonal antibody

Mesh:

Substances:

Year:  2016        PMID: 27918691      PMCID: PMC5206701          DOI: 10.1089/mab.2016.0040

Source DB:  PubMed          Journal:  Monoclon Antib Immunodiagn Immunother        ISSN: 2167-9436


  22 in total

1.  Evaluation of anti-podoplanin rat monoclonal antibody NZ-1 for targeting malignant gliomas.

Authors:  Yukinari Kato; Ganesan Vaidyanathan; Mika Kato Kaneko; Kazuhiko Mishima; Nidhi Srivastava; Vidyalakshmi Chandramohan; Charles Pegram; Stephen T Keir; Chien-Tsun Kuan; Darell D Bigner; Michael R Zalutsky
Journal:  Nucl Med Biol       Date:  2010-10       Impact factor: 2.408

2.  Chimeric anti-podoplanin antibody suppresses tumor metastasis through neutralization and antibody-dependent cellular cytotoxicity.

Authors:  Mika Kato Kaneko; Akiko Kunita; Shinji Abe; Yuta Tsujimoto; Masashi Fukayama; Kaoru Goto; Yoshihiko Sawa; Yasuhiko Nishioka; Yukinari Kato
Journal:  Cancer Sci       Date:  2012-08-27       Impact factor: 6.716

3.  Identification of a 40-kDa cell surface sialoglycoprotein with the characteristics of a major influenza C virus receptor in a Madin-Darby canine kidney cell line.

Authors:  G Zimmer; H D Klenk; G Herrler
Journal:  J Biol Chem       Date:  1995-07-28       Impact factor: 5.157

4.  Increased expression of podoplanin in malignant astrocytic tumors as a novel molecular marker of malignant progression.

Authors:  Kazuhiko Mishima; Yukinari Kato; Mika Kato Kaneko; Ryo Nishikawa; Takanori Hirose; Masao Matsutani
Journal:  Acta Neuropathol       Date:  2006-04-05       Impact factor: 17.088

5.  Anti-podoplanin Monoclonal Antibody LpMab-7 Detects Metastatic Lesions of Osteosarcoma.

Authors:  Mika K Kaneko; Hiroharu Oki; Satoshi Ogasawara; Michiaki Takagi; Yukinari Kato
Journal:  Monoclon Antib Immunodiagn Immunother       Date:  2015-06

6.  PMab-38 Recognizes Canine Podoplanin of Squamous Cell Carcinomas.

Authors:  Mika K Kaneko; Ryusuke Honma; Satoshi Ogasawara; Yuki Fujii; Takuro Nakamura; Noriko Saidoh; Michiaki Takagi; Yumiko Kagawa; Satoru Konnai; Yukinari Kato
Journal:  Monoclon Antib Immunodiagn Immunother       Date:  2016-10

7.  Specific Detection of Dog Podoplanin Expressed in Renal Glomerulus by a Novel Monoclonal Antibody PMab-38 in Immunohistochemistry.

Authors:  Ryusuke Honma; Mika K Kaneko; Satoshi Ogasawara; Yuki Fujii; Satoru Konnai; Michiaki Takagi; Yukinari Kato
Journal:  Monoclon Antib Immunodiagn Immunother       Date:  2016-07-05

8.  Molecular analysis of the pathophysiological binding of the platelet aggregation-inducing factor podoplanin to the C-type lectin-like receptor CLEC-2.

Authors:  Yukinari Kato; Mika Kato Kaneko; Akiko Kunita; Hiromi Ito; Akihiko Kameyama; Satoshi Ogasawara; Nana Matsuura; Yasushi Hasegawa; Katsue Suzuki-Inoue; Osamu Inoue; Yukio Ozaki; Hisashi Narimatsu
Journal:  Cancer Sci       Date:  2007-10-18       Impact factor: 6.716

9.  A novel targeting therapy of malignant mesothelioma using anti-podoplanin antibody.

Authors:  Shinji Abe; Yuki Morita; Mika Kato Kaneko; Masaki Hanibuchi; Yuta Tsujimoto; Hisatsugu Goto; Soji Kakiuchi; Yoshinori Aono; Jun Huang; Seidai Sato; Masatoshi Kishuku; Yuki Taniguchi; Mami Azuma; Kazuyoshi Kawazoe; Yoshitaka Sekido; Seiji Yano; Shin-ichi Akiyama; Saburo Sone; Kazuo Minakuchi; Yukinari Kato; Yasuhiko Nishioka
Journal:  J Immunol       Date:  2013-05-20       Impact factor: 5.422

10.  Molecular identification of Aggrus/T1alpha as a platelet aggregation-inducing factor expressed in colorectal tumors.

Authors:  Yukinari Kato; Naoya Fujita; Akiko Kunita; Shigeo Sato; Mika Kaneko; Motoki Osawa; Takashi Tsuruo
Journal:  J Biol Chem       Date:  2003-10-01       Impact factor: 5.157

View more
  5 in total

1.  The mouse-canine chimeric anti-dog podoplanin antibody P38B exerts antitumor activity in mouse xenograft models.

Authors:  Yukinari Kato; Tomokazu Ohishi; Manabu Kawada; Naoya Maekawa; Satoru Konnai; Shunsuke Itai; Shinji Yamada; Mika K Kaneko
Journal:  Biochem Biophys Rep       Date:  2018-11-24

2.  Chromatin run-on sequencing analysis finds that ECM remodeling plays an important role in canine hemangiosarcoma pathogenesis.

Authors:  Chinatsu Mukai; Eunju Choi; Kelly L Sams; Elena Zu Klampen; Lynne Anguish; Brooke A Marks; Edward J Rice; Zhong Wang; Lauren A Choate; Shao-Pei Chou; Yukinari Kato; Andrew D Miller; Charles G Danko; Scott A Coonrod
Journal:  BMC Vet Res       Date:  2020-06-22       Impact factor: 2.741

3.  Phase I/II Clinical Trial of the Anti-Podoplanin Monoclonal Antibody Therapy in Dogs with Malignant Melanoma.

Authors:  Satoshi Kamoto; Masahiro Shinada; Daiki Kato; Sho Yoshimoto; Namiko Ikeda; Masaya Tsuboi; Ryohei Yoshitake; Shotaro Eto; Yuko Hashimoto; Yosuke Takahashi; James Chambers; Kazuyuki Uchida; Mika K Kaneko; Naoki Fujita; Ryohei Nishimura; Yukinari Kato; Takayuki Nakagawa
Journal:  Cells       Date:  2020-11-23       Impact factor: 6.600

4.  Establishment of P38Bf, a Core-Fucose-Deficient Mouse-Canine Chimeric Antibody Against Dog Podoplanin.

Authors:  Yukinari Kato; Takuya Mizuno; Shinji Yamada; Takuro Nakamura; Shunsuke Itai; Miyuki Yanaka; Masato Sano; Mika K Kaneko
Journal:  Monoclon Antib Immunodiagn Immunother       Date:  2018-11

5.  Antibody-Drug Conjugates Using Mouse-Canine Chimeric Anti-Dog Podoplanin Antibody Exerts Antitumor Activity in a Mouse Xenograft Model.

Authors:  Yukinari Kato; Yuji Ito; Tomokazu Ohishi; Manabu Kawada; Takuro Nakamura; Yusuke Sayama; Masato Sano; Teizo Asano; Miyuki Yanaka; Saki Okamoto; Saori Handa; Yu Komatsu; Junko Takei; Mika K Kaneko
Journal:  Monoclon Antib Immunodiagn Immunother       Date:  2020-03-17
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.